IP Library Granted Patent US 9,186,364
Granted Patent B2
US 9,186,364 · App. 13/733,729 · Granted Nov 17, 2015

Formulations of deoxycholic acid and salts thereof

Inventors: Robert Emil Hodge (McPherson, KS); Jeffrey Douglas Webster (Thousand Oaks, CA)
Assignee: KYTHERA BIOPHARMACEUTICALS, INC.
A61K31/57A61K31/575
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,186,364
App. No.
13/733,729
Granted
Nov 17, 2015
Kind
B2
Abstract

The present application is directed to an aqueous pharmaceutical formulation comprising less than about 5% w/v sodium deoxycholate maintained at a pH sufficient to substantially inhibit precipitation of the sodium deoxycholate. Also disclosed herein, are methods for inhibiting precipitation of sodium deoxycholate in an aqueous solution comprising less than about 5% w/v of sodium deoxycholate, said method comprising maintaining pH of the solution of from at least about 8.0 to about 8.5.

Claims (9)

1. A method for substantially inhibiting precipitation of sodium deoxycholate in an aqueous solution consisting of less than 5% w/v of sodium deoxycholate and optionally at least one of pharmaceutically acceptable excipient and/or carrier, said method comprising maintaining pH of the solution from about 8.0 to about 8.5 thereby substantially inhibiting precipitation of the sodium deoxycholate.

2. The method of claim 1 , wherein the precipitation of sodium deoxycholate is substantially inhibited for a period of at least six months.

3. The method of claim 1 , wherein one of the at least one of pharmaceutically acceptable excipient and/or carrier is about 1% benzyl alcohol.

4. The method of claim 1 , wherein one of the at least one of pharmaceutically acceptable excipient and/or carrier is about 1% sodium chloride.

5. The method of claim 1 , wherein the aqueous solution has a pH of about 8.3.

6. The method of claim 5 , wherein the aqueous solution has a pH of 8.3.

7. The method of claim 1 , wherein the sodium deoxycholate in solution has a relative standard deviation for homogeneity of less than about 5%.

8. The method of claim 1 , wherein the aqueous solution comprises a sodium deoxycholate concentration from about 0.05% w/v to about 5% w/v.

9. A method for substantially inhibiting precipitation of sodium deoxycholate in an aqueous solution consisting of about 0.5% to about 1.5% w/v of sodium deoxycholate and optionally at least one of pharmaceutically acceptable excipient and/or carrier, said method comprising maintaining pH of the solution from about 8.0 to about 8.5 thereby substantially inhibiting precipitation of the sodium deoxycholate.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Nov 21, 2019
From: KYTHERA BIOPHARMACEUTICALS, LLC; ALLERGAN SALES, LLC
To: ALLERGAN SALES, LLC
Reel/Frame 051082/0557 →
CHANGE OF NAME Recorded Oct 9, 2019
From: KYTHERA BIOPHARMACEUTICALS, INC.
To: KYTHERA BIOPHARMACEUTICALS, LLC
Reel/Frame 051798/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2013
From: HODGE, ROBERT EMIL; WEBSTER, JEFFREY DOUGLAS
To: KYTHERA BIOPHARMACEUTICALS, INC.
Reel/Frame 030270/0914 →
Continuity (4)
Continuation 13323605 · Dec 12, 2011
Continuation 12716070 · Mar 2, 2010
Provisional Application 61274129 · Mar 3, 2009
Related Publication 20130190282A1 · Jul 25, 2013